Ménière's disease

Handbook of Clinical Neurophysiology

Volumn 9, Issue C, 2010, Pages 371-381

  Carey, John P ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957039579     PISSN: 15674231     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1567-4231(10)09028-3     Document Type: Review

References (102)

1. Albers F.W.J., van Weissenbruch R., and Casselman J.W. 3DFT-magnetic resonance imaging of the inner ear in Ménière's disease. Acta Otolaryngol. (Stockh.) 114 (1994) 595-600
2. Anatoli-Candela F. The histopatholgy of Ménière's disease. Acta Otolaryngol. Suppl. (Stockh.) 340 (1976) 5-42
3. Anderson J.P., and Harris J.P. Impact of Ménière's disease on quality of life. Otol. Neurotol. 22 (2001) 888-894
4. Balkany T.J., Sires B., and Arenberg I.K. Bilateral aspects of Ménière's disease: an underestimated clinical entity. Otolaryngol. Clin. N. Am. 13 (1980) 603-609
5. Baloh R.W. Prosper Ménière and his disease. Arch. Neurol. 58 (2001) 1151-1156
6. Baloh R.W., Jacobson K., and Winder T. Drop attacks with Ménière's syndrome. Ann. Neurol. 28 (1990) 384-387
7. Barber H.O. Ménière's disease: symptomatology. In: Oosterveld W.J. (Ed). Ménière's Disease: A Comprehensive Appraisal (1983), John Wiley, New York 25-34
8. Barrs D.M., Keyser J.S., Stallworth C., et al. Intratympanic steroid injections for intractable Ménière's disease. Laryngoscope 111 (2001) 2100-2104
9. Black F.O., and Kitch R. A review of vestibular test results in Ménière's disease. Otolaryngol. Clin. N. Am. 13 (1980) 631-642
10. Blakley B.W. Update on intratympanic gentamicin for Ménière's disease. Laryngoscope 110 (2000) 236-240
11. Boleas-Aguirre M.S., Lin F.R., La Santina C.C., et al. Longitudinal results with intratympanic dexamethasone in the treatment of Ménière's disease. Otol. Neurotol. 29 (2008) 33-38
12. Brackmann D.E., and Nissen R.L. Ménière's disease: results of treatment with the endolymphatic subarachnoid shunt compared with the endolymphatic mastoid shunt. Am. J. Otol. 8 (1987) 275-282
13. Brown J.S. A ten year statistical follow-up of 245 consecutive cases of endolymphatic shunt and decompression with 328 consecutive cases of labyrinthectomy. Laryngoscope 93 (1983) 1419-1424
14. Campbell K.C.M., Harker L.A., and Abbas P.J. Interpretation of electrocochleography in Ménière's disease and normal subjects. Ann. Otol. Rhinol. Laryngol. 101 (1992) 496-500
15. Carey J.P., Minor L.B., Peng G.C., et al. Changes in the three-dimensional angular vestibulo-ocular reflex following intratympanic gentamicin for Ménière's disease. J. Assoc. Res. Otolaryngol. 3 (2002) 430-443
16. Chia S.H., Gamst A.C., Anderson J.P., et al. Intratympanic gentamicin therapy for Ménière's disease: a meta-analysis. Otol. Neurotol. 25 (2004) 544-552
17. De Waele C., Meguenni R., Freyss G., et al. Intratympanic gentamicin injections for Ménière disease - vestibular hair cell impairment and regeneration. Neurology 59 (2002) 1442-1444
18. Ferraro J., Best L.G., and Arenberg I.K. The use of electrocochleography in the diagnosis, assessment, and monitoring of endolymphatic hydrops. Otolaryngol. Clin. N. Am. 16 (1983) 69-82
19. Filipo R., Lazzari R., Barbara M., et al. Psychologic evolution of patients with Ménières disease in relation to therapy. Am. J. Otol. 9 (1988) 306-309
20. Fitzgerald D.C., and Mark A.S. Endolymphatic duct/sac enhancement on gadolinium magnetic resonance imaging of the inner ear: preliminary observations and case reports. Am. J. Otol. 17 (1996) 603-606
21. Frew I.J., and Menon G.N. Betahistine hydrochloride in Ménière's disease. Postgrad. Med. J. 52 (1976) 501-503
22. Friberg U., Stahle J., and Svedberg A. The natural course of Ménière's disease. Acta Otolaryngol. Suppl. (Stockh.) 406 (1984) 72-77
23. Fukuda S., Keithley E.M., and Harris J.P. The development of endolymphatic hydrops following CMV inoculation of the endolymphatic sac. Laryngoscope 98 (1988) 439-443
24. Gacek R.R., and Gacek M.R. Ménière's disease: a form of vestibular ganglionitis. Adv. Otorhinolaryngol. 60 (2002) 67-79
25. Garduno-Anaya M.A., Couthino D.T., Hinojosa-Gonzalez R., et al. Dexamethasone inner ear perfusion by intratympanic injection in unilateral Ménière's disease: a two-year prospective, placebo-controlled, double-blind, randomized trial. Otolaryngol. Head Neck Surg. 133 (2005) 285-294
26. Gates G.A., Green Jr. J.D., Tucci D.L., et al. The effects of transtympanic micropressure treatment in people with unilateral Ménière's disease. Arch. Otolaryngol. Head Neck Surg. 130 (2004) 718-725
27. Gates G.A., Verrall A., Green Jr. J.D., et al. Meniett clinical trial: long-term follow-up. Arch. Otolaryngol. Head Neck Surg. 132 (2006) 1311-1316
28. Glasscock M.E., Gulya A.J., Pensak M.L., et al. Medical and surgical management of Ménière's disease. Am. J. Otol. 5 (1984) 536-542
29. Glasscock M.E., Thedinger B.A., Cueva R.A., et al. An analysis of the retrolabyrinthine vs. the retrosigmoid vestibular nerve section. Otalaryngol. Head Neck Surg. 104 (1991) 88-95
30. Hallpike C.S., and Cairns H. Observations on the pathology of Ménière's syndrome. J. Laryngol. Otol. 53 (1938) 625-655
31. Halmagyi G.M., and Curthoys I.S. A clinical sign of canal paresis. Arch. Neurol. 45 (1988) 737-739
32. Harner S.G., Driscoll C.L., Facer G.W., et al. Long-term follow-up of transtympanic gentamicin for Ménière's syndrome. Otol. Neurotol. 22 (2001) 210-214
33. Harris J.P. Autoimmunity of the inner ear. Am. J. Otol. 10 (1989) 193-195
34. Harris J.P., and Sharp P.A. Inner ear autoantibodies in patients with rapidly progressive sensorineural hearing loss. Laryngoscope 100 (1990) 516-524
35. Hirvonen T.P., Minor L.B., Hullar T.E., et al. Effects of intratympanic gentamicin on vestibular afferents and hair cells in the chinchilla. J. Neurophysiol. 93 (2005) 643-655
36. Horner K.C. Review: Morphological changes associated with endolymphatic hydrops. Scanning Microsc. 7 (1993) 223-238
37. Ishiyama G., Ishiyama A., and Baloh R.W. Drop attacks and vertigo secondary to a non-Ménière otologic cause. Arch. Neurol. 60 (2003) 71-75
38. Jackson C.G., Glasscock M.E., Hughes G.B., et al. Medical management of Ménières disease. Ann. Otol. Rhinol. Laryngol. 90 (1981) 142-147
39. Kawauchi H., Kaneda N., Ichimiya I., et al. Distribution of immunocompetent cells in the endolymphatic sac. Ann. Otol. Rhinol. Laryngol. 101 (1992) 39-47
40. Kimura R.S. Experimental blockage of the endolymphatic duct and sac and its effect on the inner ear of the guinea pig: a study of endolymphatic hydrops. Ann. Otol. Rhinol. Laryngol. 76 (1967) 664-687
41. Kinney S.E., Sandridge S.A., and Newman C.W. Long-term effects of Ménière's disease on hearing and quality of life. Am. J. Otol. 18 (1997) 67-73
42. Kitahara M. Bilateral aspects of Ménière's disease: Ménière's disease with bilateral fluctuant hearing loss. Acta Otolaryngol. (Stockh.) 485 (1991) 74-77
43. Kitahara M., Takeda T., Yazawa Y., et al. Pathophysiology of Ménière's disease and its subvarieties. Acta Otolaryngol. Suppl. (Stockh.) 406 (1984) 52-55
44. Klockhoff I., and Lindblom U. Ménière's disease and hydrochlorothiazide (Dichlotride®): a critical analysis of symptoms and therapeutic effects. Acta Otolaryngol. (Stockh.) 63 (1967) 347-365
45. Lange G. Ototoxische Antibiotika in der Behandlung des Morbus Ménière. Therapie Woche Wochenschrift Fur Praktische Medizin 26 (1976) 1-6
46. Lee K.S., and Kimura R.S. Ischemia of the endolymphatic sac. Acta Otolaryngol. (Stockh.) 112 (1992) 658-666
47. Lermoyez M. Le vertige qui fait entendre (angiospasme labyrinthique). Presse Méd. 27 (1919) 1-3
48. Lin F.R., Migliaccio A.A., Haslwanter T., et al. Angular vestibulo-ocular reflex gains correlate with vertigo control after intratympanic gentamicin treatment for Ménière's disease. Ann. Otol. Rhinol. Laryngol. 114 (2005) 777-785
49. Lustig L.R., Yeagle J., Niparko J.K., et al. Cochlear implantation in patients with bilateral Ménière's syndrome. Otol. Neurotol. 24 (2003) 397-403
50. Mark A.S. Contrast-enhanced magnetic resonance imaging of the temporal bone. Neuroimaging Clin. N. Am. 4 (1994) 117-131
51. Meyer E.D. [Treatment of Ménière disease with betahistine dimesilate (Aequamen)-double-blind study versus placebo (crossover)]. Laryngol. Rhinol. Otol. (Stuttg.) 64 (1985) 269-272
52. Minor L.B. Intratympanic gentamicin for control of vertigo in Ménière's disease: vestibular signs that specify completion of therapy. Am. J. Otol. 20 (1999) 209-219
53. Mira E., Guidetti G., Ghilardi L., et al. Betahistine dihydrochloride in the treatment of peripheral vestibular vertigo. Eur. Arch. Otorhinolaryngol. 260 (2003) 73-77
54. Moffat D.A. Endolymphatic sac surgery: analysis of 100 operations. Clin. Otolaryngol. 19 (1994) 261-266
55. Monsell E.M., and Wiet R.J. Endolymphatic sac surgery: methods of study and results. Am. J. Otol. 9 (1988) 396-402
56. Monsell E.M., Balkany T.A., Gates G.A., et al. Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Ménière's disease. Otalaryngol. Head Neck Surg. 113 (1995) 181-185
57. Moscicki R.A., San Martin J.E., Quintero C.H., et al. Serum antibody to inner ear proteins in patients with progressive hearing loss. JAMA 272 (1994) 611-616
58. Nadol J.B. Positive Hennebert's sign in Ménière's disease. Arch. Otolaryngol. Head Neck Surg. 103 (1977) 524-530
59. Niyazov D.M., Andrews J.C., Strelioff D., et al. Diagnosis of endolymphatic hydrops in vivo with magnetic resonance imaging. Otol. Neurotol. 22 (2001) 813-817
60. Oosterveld W.J. Betahistine dihydrochloride in the treatment of vertigo of peripheral vestibular origin. A double-blind placebo-controlled study. J. Laryngol. Otol. 98 (1984) 37-41
61. Orchik D.J., Shea J.J., and Ge X. Transtympanic electrocochleography in Ménière's disease using clicks and tone-bursts. Am. J. Otol. 14 (1993) 290-294
62. Paparella M.M. The cause (multifactorial inheritance) and pathogenesis (endolymphatic malabsorption) of Ménière's disease and its symptoms (mechanical and chemical). Acta Otolaryngol. (Stockh.) 99 (1985) 445
63. Paparella M.M., and Mancini F. Vestibular Ménière's disease. Otalaryngol. Head Neck Surg. 93 (1985) 148-151
64. Parker W. Ménière's disease: etiologic considerations. Arch. Otolaryngol. Head Neck Surg. 121 (1995) 377-382
65. Parnes L.S., Sun A.H., and Freeman D.J. Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope 109 (1999) 1-17
66. Peron D.L., Kitamura K., Carniol P.J., et al. Clinical and experimental results with focused ultrasound. Laryngoscope 93 (1983) 1217-1221
67. Pondugula S.R., Sanneman J.D., Wangemann P., et al. Glucocorticoids stimulate cation absorption by semicircular canal duct epithelium via epithelial sodium channel. Am. J. Physiol. Renal. Physiol. 286 (2004) F1127-F1135
68. Radtke A., Lempert T., Gresty M.A., et al. Migraine and Ménière's disease: is there a link?. Neurology 59 (2002) 1700-1704
69. Rauch S.D., Merchant S.N., and Thedinger B.A. Ménière's syndrome and endolymphatic hydrops: double-blind temporal bone study. Ann. Otol. Rhinol. Laryngol. 98 (1989) 873-883
70. Rauch S.D., San Martin J., Moscicki R.A., et al. Serum antibodies against heat shock protein 70 in Ménière's disease. Am. J. Otol. 16 (1995) 648-652
71. Rauch S.D., Zhou G., Kujawa S.G., et al. Vestibular evoked myogenic potentials show altered tuning in patients with Ménière's disease. Otol. Neurotol. 25 (2004) 333-338
72. Rizvi S.S. Investigations into the cause of canal paresis in Ménière's disease. Laryngoscope 96 (1986) 1258-1271
73. Salt A.N. Acute endolymphatic hydrops generated by exposure of the ear to nontraumatic low-frequency tones. J. Assoc. Res. Otolaryngol. 5 (2004) 203-214
74. Salt A.N., Henson M.M., Gewalt S.L., et al. Detection and quantification of endolymphatic hydrops in the guinea pig cochlea by magnetic resonance microscopy. Hear. Res. 88 (1995) 79-86
75. Schuknecht H.F. Ablation therapy in the management of Ménière's disease. Acta Otolaryngol. Suppl. (Stockh.) 132 (1957) 1-42
76. Schuknecht H.F. Ménière's disease: a correlation of symptomatology and pathology. Laryngoscope (1963) 651-665
77. Schuknecht H.F. Pathology of the Ear (1974), Harvard University, Massachusetts
78. Schuknecht H.F. Endolymphatic hydrops - can it be controlled?. Ann. Otol. Rhinol. Laryngol. 95 (1986) 36-39
79. Schuknecht H.F., and Igarashi M. Pathophysiology of Ménière's disease. In: Pfaltz C.R. (Ed). Controversial Aspects of Ménière's Disease (1986), Georg Thieme, New York
80. Schuknecht H.F., Suzuka Y., and Zimmermann C. Delayed endolymphatic hydrops and its relationship to Ménière's disease. Ann. Otol. Rhinol. Laryngol. 99 (1990) 843-853
81. Shea J.J., and Ge X. Dexamethasone perfusion of the labyrinth plus intravenous dexamethasone for Ménière's disease. Otolaryngol. Clin. N. Am. 29 (1996) 353-358
82. Silverstein H., Smouha E., and Jones R. Natural history vs. surgery for Ménière's disease. Otalaryngol. Head Neck Surg. 100 (1989) 6-16
83. Silverstein H., Isaacson J.E., Olds M.J., et al. Dexamethasone inner ear perfusion for the treatment of Ménière's disease: a prospective, randomized, double-blind, crossover trial. Am. J. Otol. 19 (1998) 196-201
84. Stahle J. Advanced Ménière's disease: a study of 356 severely disabled patients. Acta Otolaryngol. (Stockh.) 81 (1976) 113-119
85. Stahle J., and Klockhoff I. Diagnostic procedures, differential diagnosis and general conclusions. In: Pfaltz C.R. (Ed). Controversial Aspects of Ménière's Disease (1986), George Thieme, New York 71-86
86. Strupp M., Hupert D., Frenzel C., et al. Long-term prophylactic treatment of attacks of vertigo in Ménière's disease - comparison of a high with a low dosage of betahistine in an open trial. Acta Otolaryngol. 128 (2008) 520-524
87. Suga F., and Snow J.B. Cochlear blood flow in response to vasodilating drugs and some related agents. Laryngoscope 79 (1941) 1956-1979
88. Thomas K., and Harrison M.S. Long term follow-up of 610 cases of Ménière's disease. Proc. R. Soc. Med. 64 (1971) 853-856
89. Thomsen J., and Bretlau P. General conclusions. In: Pfaltz C.R. (Ed). Controversial Aspects of Ménière's Disease (1986), Georg Thiem, New York
90. Thomsen J., Bretlau P., Tos M., et al. Placebo effect in surgery for Ménière's disease: a double-blind, placebo-controlled study on endolymphatic sac shunt surgery. Arch. Otolaryngol. Head Neck Surg. 107 (1981) 271-277
91. Thomsen J., Tos M., Bretlau P., et al. Endolymphatic sac-mastoid shunt surgery: a nonspecific treatment modality?. Ann. Otol. Rhinol. Laryngol. 95 (1986) 32-35
92. Thomsen J., Sass K., Odkvist L., et al. Local overpressure treatment reduces vestibular symptoms in patients with Ménière's disease: a clinical, randomized, multicenter, double-blind, placebo-controlled study. Otol. Neurotol. 26 (2005) 68-73
93. Tomiyama S., Yagi T., Sakagami M., et al. Immunological pathogenesis of endolymphatic hydrops and its relation to Ménière's disease. Scanning Microsc. 7 (1993) 907-920
94. Torok N. Old and new in Ménière disease. Laryngoscope 87 (1977) 1870-1877
95. Trune D.R., Kempton J.B., and Kessi M. Aldosterone (mineralocorticoid) equivalent to prednisolone (glucocorticoid) in reversing hearing loss in MRL/MpJ-Fas1pr autoimmune mice. Laryngoscope 110 (2000) 1902-1906
96. Tumarkin A. The otolithic catastrophe: a new syndrome. Br. Med. J. (Clin. Res. Ed.) 2 (1936) 175-177
97. Valvassori G.E., and Dobben G.D. Multidirectional and computerized tomography of the vestibular aqueduct in Ménière's disease. Ann. Otol. Rhinol. Laryngol. 93 (1984) 547-550
98. Van Deelen G.W., and Huizing E.H. Use of a diuretic (Dyazide®) in the treatment of Ménière's disease. ORL. J. Otorhinolaryngol. Relat. Spec. 48 (1986) 287-292
99. Vass Z., Steyger P.S., Hordichok A.J., et al. Capsaicin stimulation of the cochlea and electric stimulation of the trigeminal ganglion mediate vascular permeability in cochlear and vertebro-basilar arteries: a potential cause of inner ear dysfunction in headache. Neuroscience 103 (2001) 189-201
100. Wladislavosky-Waserman P., Facer G.W., Bahram M., et al. Ménière's disease: a 30-year epidemiologic and clinical study in Rochester, MN, 1951-1980. Laryngoscope 94 (1984) 1098-1102
101. Xenellis J., Morrison A.W., Mcclowskey D., et al. HLA antigens in the pathogenesis of Ménières disease. J. Laryngol. Otol. 100 (1986) 21-24
102. Yoshino K., Ohashi T., Urushibata T., et al. Antibodies to type II collagen and immune complexes in Ménière's disease. Acta Otolaryngol. (Stockh.) (1996) 79-85